NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
November 10, 2025 — LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa “one day” (ONE-D) protocol for treatment-resistant depression - the first deployment of its kind in Florida and among the first nationwide. The Ampa device combines a single day of transcranial magnetic stimulation (TMS) with physician-prescribed D-cycloserine and lisdexamfetamine, which in peer-reviewed studies have shown response rates of 87% and remission rates of 72% in nonrandomized trials.
November 10, 2025 — LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a global leader in quantum computing systems, software and services, and Davidson Technologies, Inc.
November 10, 2025 — Research Highlights: Among 150 adults who had been recently hospitalized for heart failure, those who received deliveries of prepared meals or fresh produce along with dietary counseling reported improved quality of life compared to adults who only received dietary guidance without food delivery. There were no differences in the number of hospital readmissions or emergency department visits for heart failure between participants who received food delivery compared to those who did not.
November 10, 2025 — Research Highlights: The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a placebo plus statin, according to the results of a new clinical trial. Researchers found alirocumab did not reduce the risk of developing cardiac allograft vasculopathy, a progressive coronary artery disease that occurs after a heart transplant.
November 10, 2025 — Premier Technology Investment Forum to Connect 100+ Companies With Institutional Investors November 18-19 in New York The ROTH Technology Conference, a B2i Digital Featured Conference, Will be Showcased to B2i Digital’s Community of More Than 1. 4 Million Investors NEW YORK, NY - November 10, 2025 (NEWMEDIAWIRE) - B2i Digital, Inc.
November 10, 2025 — Research Highlights: Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, had improved heart function and symptoms, better quality of life, fewer hospitalizations and greater medication adherence in comparison to those who took the same medications as separate pills. This is the first study to evaluate a polypill strategy in people with HFrEF, focused on improving medication adherence and simplifying treatment.
November 10, 2025 — Research Highlights: Chest pain may still be angina even when the main heart arteries look clear. Using cardiac stress MRI (a heart scan that measures blood flow with magnetic resonance imaging), testing uncovered small vessel problems in about half of participants in a study of people who had prior coronary angiography that indicated no obstructive coronary artery disease.
November 10, 2025 — Research Highlights: Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patients with Type 1 or Type 2 diabetes who had undergone stent placement, a procedure done to keep an artery open, and free of clots or a blockage. While both medications help prevent platelets from clumping together and forming a clot in a stent, the study showed they may not offer the same level of benefits in the patients studied.
November 10, 2025 — Positioning GeoVax as a Diversified, Made-in-America Vaccine Leader with Global Market Relevance ATLANTA, GA - November 10, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today recognized World Immunization Day, a global observance highlighting the lifesaving power of vaccines and the urgent need to address rising concerns about vaccine confidence.
November 10, 2025 — Embargoed until 4:00 am CT/5:00 am ET, Monday, Nov. 10, 2025 DALLAS, TX - November 10, 2025 (NEWMEDIAWIRE) - Hundreds of health care artificial intelligence (AI) tools have been cleared by the U.
November 9, 2025 — Smart Technology and Sustainability Take Centre Stage The Hong Kong International Optical Fair came to a successful conclusion today, attracting some 12,000 buyers keen on sourcing and procurement Buyers from outside Hong Kong primarily came from the Chinese Mainland, Taiwan, India, Japan, Korea, the US, and ASEAN countries such as Indonesia, Malaysia, the Philippines and Thailand Fair products focused on key market trends - “smart technology”, “sustainability”, “silver healthcare” and “functionality & design” - featuring the industry's latest achievements in technological innovation and sustainability Results of the 25th Hong Kong Eyewear Design Competition showcased award-winning entries from local designers HONG KONG - November 9, 2025 (NEWMEDIAWIRE) - 7 November 2025, The 33rd Hong Kong International Optical Fair, organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Optical Manufacturers Association (HKOMA), concluded successfully today. The three-day fair attracted some 12,000 buyers from 92 countries and regions.
November 9, 2025 — Wine & Spirits Zone in the Spotlight With Global Demand for Diverse Wines and Spirits The three-day 17th Hong Kong International Wine & Spirits Fair ended yesterday, attracting over 8,200 trade buyers from 57 countries and regions The new “World of Spirits” zone showcased spirits from 14 countries and regions, featuring six of the “Top 10 Chinese Baijiu Brands” Homegrown brands injected authentic Hong Kong character and gained recognition from overseas buyers. HONG KONG - November 9, 2025 (NEWMEDIAWIRE) - The 17th Hong Kong International Wine & Spirits Fair (Wine & Spirits Fair), organised by the Hong Kong Trade Development Council (HKTDC), successfully wrapped up yesterday.
November 9, 2025 — Research Highlights: Adults in rural villages in China who participated in the Healthy Family Program, a family-based intervention that involved regular blood pressure monitoring, the use of low-sodium salt substitutes and educational sessions on healthy lifestyle habits, achieved an average of 10 mm Hg reduction in systolic blood pressure compared to adults who did not participate in the program. Six months after the program ended, the average systolic blood pressure for people who lived in participating villages remained 3.
November 9, 2025 — Research Highlights: A grocery support program based on the low-sodium DASH eating plan that included home-delivered groceries and dietary counseling reduced blood pressure levels in Black adults living in areas where grocery stores were inaccessible or scarce, known as food deserts. People who had groceries delivered to their homes and followed guidance from a dietitian for three months had greater improvements in blood pressure and cholesterol levels, compared to a similar group in the same community who were given a monthly stipend to purchase groceries and plan meals on their own.
November 9, 2025 — Research Highlights: A study of 400 adults with high blood pressure found that participants were twice as likely to take their blood pressure medication (measured by electronic pill bottles that recorded when bottles were opened) when they could win a daily cash reward compared to people who were not offered a potential reward. Despite taking their blood pressure medication more consistently, participants who were eligible for cash rewards had similar blood pressure reductions compared to the people who were not offered rewards.
November 9, 2025 — DALLAS, TX - November 9, 2025 (NEWMEDIAWIRE) - More than 28 million people worldwide are living with heart valve disease, and the numbers are climbing. In the U.
November 9, 2025 — Research Highlights: Adults with heart disease prescribed vitamin D in doses tailored to reach blood levels considered optimal for heart health (>40-80 ng/mL) had a reduced risk of heart attack by more than half (52%) compared to those who did not receive monitoring of vitamin D levels. 85% of all study participants had vitamin D levels below 40 ng/mL at enrollment, and nearly 52% of people in the treatment group needed to take more than 5,000 IU of vitamin D each day (more than six times the 800 IU daily value established by the FDA) to reach target blood levels of 40-80 ng/mL.
November 9, 2025 — Research Highlights: During the 6 months after treatment to restore a normal heart rhythm, adults with atrial fibrillation (AFib) who were randomly assigned to drink coffee every day were 39% less likely to have a recurrence of AFib compared to participants assigned to not have any coffee or other caffeinated drinks. The results of the 200-person trial may challenge the common belief that caffeine may spur more abnormal heart rhythms such as AFib.
November 9, 2025 — Research Highlights: Adults with atrial fibrillation and obesity/overweight (but no diabetes) who took the diabetes medication metformin after a rhythm correction procedure were more likely to stay free of AFib episodes for a year. Weight loss was not thought to be the main reason metformin helped, since there was only a modest weight change among those taking the medication.
